Department of Health
We undertake regular activities to monitor and evaluate how well the MRFF is meeting its goals. This includes using a series of performance indicators to assess the progress and eventual impact of the MRFF.
Between March 2024 and May 2024, we conducted a survey to capture data on:
- all MRFF performance indicators across awarded grants
- a subset of indicators for completed grants.
The survey saw a robust response, with 75.5% of 1,328 MRFF grantees (1,002 respondents) participating. The results show:
- a significant 83% of MRFF-funded projects have involved consumers in their research and 83% have engaged with clinicians
- 84% of MRFF projects have focused on a priority population, while 67% have addressed emerging issues. This aligns with the MRFF's mission to direct research towards areas of unmet need
- more than half of MRFF projects involve clinical trials, with at least 744 trials supported. Notably, 59% of these trials are in rural, regional, and remote sites
- the MRFF has supported 7,527 research staff which amounts to 9,959 full-time-equivalent years. It has also attracted $787 million in co-funding and $949 million in new funding, highlighting its significant financial impact on the research community
- while longer-term indicators related to healthcare change and commercialisation show proportionately less progress, there are promising signs. Of the completed projects (14% of respondents), 42% have contributed to healthcare policy or guidelines, and 35% have influenced health professional education.
Learn more in the Results of the 2024 MRFF performance indicator survey.
/Media Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
